跳至主要内容
临床试验/DRKS00023818
DRKS00023818招募中不适用

Implementation and evaluation of mobile health tools for personalised follow-up of patients in radiation therapy for prostate cancer - PersoRad

niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde0 个研究点目标入组 130 人开始时间: 2021年1月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Male

入选标准

  • SUBSTUDY 1:
  • Prostate cancer patients under radiation with curative intent,
  • histologically proven PCA,
  • Gleason Score 6-9,
  • PSA <40 ng/ml.
  • SUBSTUDY 2:
  • Patients with primary prostate cancer of favorable-intermediate- to very-high risk after NCCN (National Comprehensive Cancer Network)
  • histologically proven PCA,
  • cT2a-3b (MRT, PET/CT),
  • cN0 und cM0 (MRT, PET/CT),
  • Gleason-Score 7-9,
  • ECOG Performance Status 0 or 1,
  • IPSS < 15,
  • size of prostate = 75 ml (as of date of radiation therapy planning)

排除标准

  • SUBSTUDIES 1 and 2: insufficient command of German language, patient too much distressed by his condition, acute psychosis, risk of suicide present.

研究者

发起方
niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde

相似试验